Approval · Notice of Compliance 12522 · 2011
REMICADE: Notice of Compliance 12522
Issued August 5, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12522
- Date
- August 5, 2011
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer Name Change
- Therapeutic class
- Biological Response Modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REMICADE | 02244016 | Marketed |
Medicinal ingredients
- INFLIXIMAB 100 MG per VIAL